The impact of incident and prevalent herpes simplex virus-2 infection on the incidence of HIV-1 infection among commercial sex workers in South Africa

Journal of Acquired Immune Deficiency Syndromes

Volumn 39, Issue 3, 2005, Pages 333-339

  Ramjee, Gita ^a   Williams, Brian ^b,g   Gouws, Eleanor ^b   Van Dyck, Eddy ^c   De Deken, Bénédicte ^c   Karim, Salim Abdool ^d,e,f  

^a SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^b Council for Scientific and Industrial Research South Africa ^*  (Switzerland)

^c INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^d UNIVERSITY OF KWAZULU NATAL   (South Africa)

^e Och Spine at New York Presbyterian Hospitals   (United States)

^f Department of Obstetrics Gynecology   (United States)

^g NONE   (Switzerland)

Author keywords

AIDS; Herpes simplex virus; HIV; Incidence; Sex worker; South Africa

Indexed keywords

HERPES SIMPLEX VIRUS ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

ADULT; ANTIBODY DETECTION; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; FEMALE; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION RISK; MALE; PREVALENCE; PRIORITY JOURNAL; PROSTITUTION; SEROPREVALENCE; SOUTH AFRICA;

ADOLESCENT; ADULT; ANTI-INFECTIVE AGENTS; FEMALE; HERPES GENITALIS; HERPESVIRUS 2, HUMAN; HIV INFECTIONS; HIV SEROPOSITIVITY; HIV-1; HUMANS; MIDDLE AGED; NONOXYNOL; PROPORTIONAL HAZARDS MODELS; PROSTITUTION; RISK FACTORS; SOUTH AFRICA; TIME FACTORS; VAGINAL CREAMS, FOAMS, AND JELLIES;

EID: 21544456925     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.qai.0000144445.44518.ea     Document Type: Article

References (26)

1. Reynolds SJ, Risbud AR, Shepherd ME, et al. Recent herpes simplex virus type 2 infection and the risk of human immunodeficiency virus type 1 acquisition in India. J Infect Dis. 2003;187:1513-1521.
2. Schomogyi M, Wald A, Corey L. Herpes simplex virus-2 infection: an emerging disease? Infect Dis Clin North Am. 1998;12:47-61.
3. Wasserheit JN. Epidemiological synergy: interrelationship between human immunodeficiency virus infection and other sexually transmitted diseases. Sex Transm Dis. 1992;19:61-77.
4. McClelland RS, Wang CC, Overbaugh J, et al. Association between cervical shedding of Herpes simples virus and HIV. AIDS. 2002;160: 2425-2430.
5. Mbopi-Keou FX, Gresenguet G, Mayaud P, et al. Interactions between herpes simplex virus type 2 and human immunodeficiency virus type 1 infection in African women: opportunities for intervention. J Infect Dis. 2000;182:1090-1096.
6. Johnson AM, Laga M. Heterosexual transmission of HIV-1. AIDS. 1988; 2:S49-S56.
7. Auvert B, Ballard R, Campbell C, et al. HIV infection among youth in a South African mining town is associated with herpes simplex virus-2 seropositivity and sexual behaviour. AIDS. 2001;15:885-898.
8. Auvert B, Buve A, Ferry B, et al. Ecological and individual level analysis of risk factors for HIV infection in four urban populations in sub-Saharan Africa with different levels of HIV infection. AIDS. 2001;15(Suppl 4): S15-S30.
9. Chen CY, Ballard RC, Beck-Sague M, et al. Human immunodeficiency virus infection and genital ulcer disease in South Africa. Sex Transm Dis. 2000;27:21-29.
10. Williams BG, Gouws E. The epidemiology of human immunodeficiency virus in South Africa. Philos Trans R Soc Lond B Biol Sci. 2001;356: 1077-1086.
11. Kilmarx PH, Limpakarnjanarat K, Mastro TD, et al. HIV seroconversion in a prospective cohort of female sex workers in Northern Thailand: continued high incidence among brothel-based women. AIDS. 1998;12: 1889-1898.
12. Weiss HA, Buve A, Robinson NJ, et al. The epidemiology of HSV-2 infection and its association with HIV infection in four urban African populations. AIDS. 2001;15(Suppl 4):S97-S108.
13. Hook EW, Cannon R, Nahmias AJ, et al. Herpes simplex virus infection as a risk factor for human immunodeficiency virus infection in heterosexuals. J Infect Dis. 1992;165:251-255.
14. Gwanzura L, McFarland W, Alexander D, et al. Association between human immunodeficiency virus and herpes simplex virus type 2 seropositivity among male factory workers in Zimbabwe. J Infect Dis. 1998; 177:481-484.
15. Wald A, Link K. Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis. J Infect Dis. 2002;185:45-52.
16. McFarland W, Gwanzura L, Bassett MT, et al. Prevalence and incidence of herpes simplex virus type 2 infection among male Zimbabwean factory workers. J Infect Dis. 1999;180:1459-1465.
17. Rodriguez M, Obasi A, Mosha F, et al. Herpes simplex virus type 2 infection increases HIV incidence: a prospective study in rural Tanzania. AIDS. 2002;16:451-462.
18. Gilson L, Mkanje R, Grosskurth H, et al. Cost-effectiveness of improved treatment services for sexually transmitted diseases in preventing HIV-1 infection in Mwanza Region, Tanzania. Lancet. 1997;350:1805-1809.
19. Ramjee G, Abdool Karim SS, Sturm A. Sexually transmitted infections among sex workers in Kwazulu-Natal, South Africa. Sex Transm Dis. 1998;25:346-349.
20. Van Damme L, Ramjee G, Alary M, et al. Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial. Lancet. 2002;360:971-977.
21. Wald A, Ashley-Morrow R. Serological testing for herpes simplex virus HSV-1 and HSV-2 infection. Clin Infect Dis. 2002;35:S173-S182.
22. Dodd RY, Notari EP, Stramer SL. Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population. Transfusion (Paris). 2002; 42:975-979.
23. Williams BG, Gouws E, Colvin M, et al. Patterns of infection: using age prevalence data to understand the epidemic of HIV in South Africa. S Afr J Sci. 2000;96:305-312.
24. Turner KR, McFarland W, Kellogg TA, et al. Incidence and prevalence of herpes simplex virus type 2 infection in persons seeking repeat HIV counseling and testing. Sex Transm Dis. 2003;30:331-334.
25. Mbopi-Keou FX, Gresenguet G, Mayaud P, et al. Genital herpes simplex virus type 2 shedding is increased in HIV-infected women in Africa. AIDS. 1999;13:536-537.
26. Wald A, Zeh J, Selke S, et al. Reactivation of genital herpes simplex virus type 2 infection is asymptomatic HSV-2 seropositive persons. N Engl J Med. 2000;342:844-850.